What does a KDIGO (Kidney Disease: Improving Global Outcomes) GFR (Glomerular Filtration Rate) category G2 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

KDIGO GFR Category G2

KDIGO GFR category G2 represents a mildly decreased kidney function with an estimated glomerular filtration rate (eGFR) of 60-89 mL/min/1.73 m², and importantly, this category alone does NOT constitute chronic kidney disease (CKD) unless accompanied by evidence of kidney damage such as albuminuria. 1

Definition and Classification

GFR Category G2 Criteria:

  • eGFR range: 60-89 mL/min/1.73 m² 1
  • Description: Kidney damage with mild decrease in GFR 1
  • Critical requirement: Must have markers of kidney damage (such as albuminuria ≥30 mg/g) present for ≥3 months to qualify as CKD 1

Clinical Significance

Key Point: G2 alone without kidney damage markers is NOT CKD. 1 The presence of structural or functional kidney abnormalities (particularly albuminuria) is essential for the diagnosis of CKD in this GFR range. 1, 2

When G2 Indicates CKD:

  • Albuminuria (albumin-to-creatinine ratio ≥30 mg/g) is present 1, 2
  • Other markers of kidney damage exist (abnormal urinary sediment, structural abnormalities on imaging, or biopsy-proven kidney disease) 1
  • Abnormalities persist for ≥3 months 1

Prognosis and Risk Stratification

The prognosis in G2 varies dramatically based on albuminuria level: 1, 3

  • G2 with normal albuminuria (<30 mg/g): Low risk for progression and mortality 3
  • G2 with moderately increased albuminuria (30-299 mg/g): Moderate risk 3
  • G2 with severely increased albuminuria (≥300 mg/g): High risk for CKD progression and cardiovascular events 3, 4

Clinical Management Approach

Monitoring Frequency: 1

  • Assess eGFR and albuminuria at least annually 1
  • More frequent monitoring if albuminuria is present or other risk factors exist 1

Interventions for G2 with Kidney Damage: 1

  • Lifestyle modifications: Smoking cessation, weight management 1
  • Blood pressure optimization: Target individualized based on albuminuria level 1
  • RAS inhibition: If albuminuria ≥30 mg/g is present 1
  • SGLT2 inhibitors: For patients with type 2 diabetes and albuminuria 1
  • Identify and treat underlying cause of kidney damage 1
  • Avoid nephrotoxins and adjust medication dosages appropriately 1

Common Clinical Pitfalls

Do not diagnose CKD based on G2 alone. 1 A healthy kidney donor with eGFR of 65 mL/min/1.73 m² and no albuminuria does NOT have CKD, despite being in the G2 range. 1

Small fluctuations in eGFR are common and not necessarily indicative of progression. 1 Confirm changes with repeat testing before concluding disease progression. 1

Consider cystatin C-based eGFR estimation if there are concerns about creatinine-based estimates being inaccurate (extremes of muscle mass, dietary factors). 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.